3-33120430-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006371.5(CRTAP):​c.558A>G​(p.Ala186Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00576 in 1,613,268 control chromosomes in the GnomAD database, including 351 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A186A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.028 ( 171 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 180 hom. )

Consequence

CRTAP
NM_006371.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.14

Publications

2 publications found
Variant links:
Genes affected
CRTAP (HGNC:2379): (cartilage associated protein) The protein encoded by this gene is similar to the chicken and mouse CRTAP genes. The encoded protein is a scaffolding protein that may influence the activity of at least one member of the cytohesin/ARNO family in response to specific cellular stimuli. Defects in this gene are associated with osteogenesis imperfecta, a connective tissue disorder characterized by bone fragility and low bone mass. [provided by RefSeq, Jul 2008]
CRTAP Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 7
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-33120430-A-G is Benign according to our data. Variant chr3-33120430-A-G is described in ClinVar as Benign. ClinVar VariationId is 195266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0904 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRTAPNM_006371.5 linkc.558A>G p.Ala186Ala synonymous_variant Exon 2 of 7 ENST00000320954.11 NP_006362.1 O75718
CRTAPNM_001393363.1 linkc.558A>G p.Ala186Ala synonymous_variant Exon 2 of 6 NP_001380292.1
CRTAPNM_001393364.1 linkc.558A>G p.Ala186Ala synonymous_variant Exon 2 of 6 NP_001380293.1
CRTAPNM_001393365.1 linkc.472-3978A>G intron_variant Intron 1 of 5 NP_001380294.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRTAPENST00000320954.11 linkc.558A>G p.Ala186Ala synonymous_variant Exon 2 of 7 1 NM_006371.5 ENSP00000323696.5 O75718
CRTAPENST00000449224.1 linkc.558A>G p.Ala186Ala synonymous_variant Exon 2 of 6 2 ENSP00000409997.1 C9JP16
CRTAPENST00000485310.1 linkn.152A>G non_coding_transcript_exon_variant Exon 2 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.0275
AC:
4186
AN:
152198
Hom.:
170
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0928
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0104
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0173
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.00822
AC:
2046
AN:
249022
AF XY:
0.00605
show subpopulations
Gnomad AFR exome
AF:
0.0921
Gnomad AMR exome
AF:
0.00434
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.0162
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000440
Gnomad OTH exome
AF:
0.00621
GnomAD4 exome
AF:
0.00349
AC:
5102
AN:
1460952
Hom.:
180
Cov.:
31
AF XY:
0.00311
AC XY:
2257
AN XY:
726866
show subpopulations
African (AFR)
AF:
0.0963
AC:
3223
AN:
33454
American (AMR)
AF:
0.00521
AC:
233
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26132
East Asian (EAS)
AF:
0.0185
AC:
736
AN:
39692
South Asian (SAS)
AF:
0.000638
AC:
55
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00780
AC:
45
AN:
5766
European-Non Finnish (NFE)
AF:
0.000301
AC:
335
AN:
1111176
Other (OTH)
AF:
0.00784
AC:
473
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
259
519
778
1038
1297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0276
AC:
4198
AN:
152316
Hom.:
171
Cov.:
32
AF XY:
0.0264
AC XY:
1970
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0928
AC:
3857
AN:
41546
American (AMR)
AF:
0.0104
AC:
159
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0173
AC:
90
AN:
5192
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0171
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
68032
Other (OTH)
AF:
0.0189
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
195
390
586
781
976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0208
Hom.:
113
Bravo
AF:
0.0309
Asia WGS
AF:
0.0150
AC:
51
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Osteogenesis imperfecta type 7 Benign:3
Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 27, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Apr 18, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Osteogenesis imperfecta Benign:1
Jun 18, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.027
DANN
Benign
0.45
PhyloP100
-3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35357409; hg19: chr3-33161922; API